London – 28 February, 2020 – Preparations are underway for the 2020 Global Generics & Biosimilars Awards from Informa Pharma Intelligence. The awards, which recognize and promote best practices across the generics, biosimilars, and value-added medicines industries, will take place Wednesday, 14 October in Milan, Italy.
"Generics Bulletin and Informa Pharma Intelligence are delighted to once again be celebrating the best and brightest of the generics, biosimilars and value added medicines industries,” said David Wallace, Executive Editor of Generics Bulletin. “The previous years’ entries have all been great examples of the dedication and commitment that these industries demonstrate every day in making more affordable treatments more accessible to ever more people around the world, and we expect the standard to be just as high this year.”
Established in 2014, the Global Generics & Biosimilars Awards are held to honor the accomplishments of those companies and individuals whose outstanding contributions are helping to improve health care worldwide by making critical medicines more affordable and more widely available.
Spanning 14 different categories, the Global Generics & Biosimilars Awards cover an array of industry activities and focus on excellence in business development initiatives. Categories highlight innovative product development and smart legal manoeuvres, and include Acquisition of the Year, Value Added Medicine Initiative of the Year, Legal Strategy of the Year, and Industry Partner of the Year. Notable contributions by companies and outstanding achievements by company leadership are also honored during the ceremony, which is free to enter and free to attend via complimentary tickets.
“We look forward to welcoming entrants and attendees alike to the Global Generics & Biosimilars Awards in Milan this October,” Wallace said, “and I am sure our panel of distinguished judges will have a tougher task than ever in selecting the winners from such a competitive field.”
For a full list of awards categories, criteria and information about how to enter a nomination, click here
About Informa Pharma Intelligence
Trusted by over 3,000 of the world’s leading pharmaceutical companies, CROs, med and biotech organizations, and healthcare service providers, the Pharma Intelligence suite of intelligence solutions delivers vital, accurate, and timely intelligence about the drug development pipeline to pharmaceutical and biomedical decision makers around the world.
At Pharma Intelligence, global teams of subject area experts follow and analyze key diseases, clinical trials, drug approvals and R&D activities as part of the breadth and depth of data available to customers. For more information visit pharmaintelligence.informa.com.